{
  "meta": {
    "title": "Rbc_And_Hemoglobin",
    "url": "https://brainandscalpel.vercel.app/rbc-and-hemoglobin-e1d506f5.html",
    "scrapedAt": "2025-11-30T11:20:09.136Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin can be produced by the liver</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Norepinephrine and epinephrine stimulate the production of erythropoietin</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoxia inducible factor 1 stimulates the production of erythropoietin</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True about erythropoietin is:</span></p>",
      "unique_key": "DT1320723",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320723,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Erythropoietin (EPO):</strong></p>\n<ul>\n<li><strong>EPO Source:</strong> Primarily the <strong>kidney</strong>, ~10% by the <strong>liver</strong>. <strong>(Option A)</strong></li>\n<li><strong>Main Stimulus: </strong>Hypoxia.</li>\n<li><strong>Key Regulator:</strong> <strong>Hypoxia-Inducible Factor 1 (HIF-1)</strong> activates EPO gene transcription. <strong>(Option C)</strong></li>\n<li><strong>Other Stimulants:</strong> <strong>Norepinephrine, epinephrine, prostaglandins, androgens. (Option B)</strong></li>\n<li><strong>Function:</strong> Stimulates <strong>RBC production</strong> (erythropoiesis) in bone marrow.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318dde27bd0-0778-42b7-8f0e-920abb236824.jpg\">",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepcidin promotes the release of iron from macrophages directly</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepcidin plays an important role in the regulation of iron absorption and distribution</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepcidin decreases the level of apotransferrin in the plasma</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male with chronic inflammation presents with anaemia. Laboratory tests show elevated hepcidin levels. Which statement is true about hepcidin's role in this patient?</span></p>",
      "unique_key": "DT1320739",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320739,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Hepcidin</strong>:</p>\n<ul>\n<li>Key <strong>iron-regulating hormone</strong>.</li>\n<li><strong>Mechanism:</strong> Binds to and causes <strong>internalisation and degradation of ferroportin</strong>.</li>\n<li><strong>Ferroportin:</strong> Cellular iron exporter found on enterocytes, macrophages, and hepatocytes.</li>\n<li><strong>Effect:</strong>\n<ul>\n<li><strong>Decreases iron absorption</strong> from the duodenum.</li>\n<li><strong>Decreases iron release</strong> from macrophages and liver stores.</li>\n<li>Leads to <strong>iron sequestration</strong> (iron trapped inside cells).</li>\n</ul>\n</li>\n<li><strong>Regulation:</strong> Levels increase with <strong>high iron stores</strong> and <strong>inflammation</strong> (e.g., IL-6). Levels decrease with <strong>iron deficiency</strong> and <strong>erythropoietic demand</strong>.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318dbbdde0e-41af-4316-9d54-99d02548629d.jpg\"><br></li>\n<li><strong>Role in Disease:</strong> Elevated in <strong>Anaemia of Chronic Disease</strong> (leads to functional iron deficiency). Deficient in <strong>Hemochromatosis</strong> (leads to iron overload).</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Hepcidin promotes the release of iron from macrophages directly (Option A):</strong> Hepcidin's action on macrophages is to trap iron within them by degrading ferroportin, thus decreasing its release into the blood, not promoting it. Ferroportin, not hepcidin, is responsible for iron export from macrophages.</p>\n<p><strong>Hepcidin decreases the level of apotransferrin in the plasma (Option C):</strong> Hepcidin directly regulates ferroportin. Apotransferrin (the iron-free form of transferrin, which transports iron in plasma) levels are influenced by overall iron status, but not directly decreased by hepcidin.</p>\n<p><strong>All of the above (Option D):</strong> This is incorrect because options A and C are false.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Hepcidin </strong>is the master<strong> regulator of iron.</strong></li>\n<li>Its primary action is to <strong>block iron export</strong> by degrading <strong>ferroportin</strong>, leading to reduced absorption and release.</li>\n</ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Cobalt salts</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgens</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory Alkalosis</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old male living at high altitude develops polycythemia due to increased erythropoietin. Besides hypoxia, which other factors stimulate erythropoietin secretion?</span></p>",
      "unique_key": "DT1320743",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320743,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Erythropoietin (EPO):</strong></p>\n<ul>\n<li><strong>Primary Stimulus: </strong>Hypoxia.</li>\n<li><strong>Other Stimuli for EPO Secretion:</strong>\n<ul>\n<li>Cobalt salts: Mimic hypoxia. <strong>(Option A)</strong></li>\n<li>Androgens (Testosterone): Direct stimulation. <strong>(Option B)</strong></li>\n<li>Respiratory Alkalosis: respiratory alkalosis stimulates EPO indirectly via reduced PCO2 and increased oxygen affinity, not as potently as hypoxia. <strong>(Option C)</strong></li>\n<li>Catecholamines: Via beta-adrenergic stimulation.</li>\n<li>Prostaglandins.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250318dde27bd0-0778-42b7-8f0e-920abb236824.jpg\">",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Macrocytic</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Normocytic</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Microcytic</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypochromic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old female visited the primary care physician for his weakness and easy fatigability. The doctor investigated her and found her MCV is 75 fl. The RBCs in this female are:</span></p>",
      "unique_key": "DT1320745",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320745,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>A normal MCV typically ranges from <strong>80 to 100 fL (femtoliters)</strong>. In this case, the female patient's MCV is 75 fL, which is <strong>less than 80 fL</strong>. RBCs with an MCV below this normal range are considered <strong>smaller than average</strong> and are therefore classified as <strong>microcytic</strong>.</p>\n<p><strong>Mean Corpuscular Volume (MCV):</strong></p>\n<ul>\n<li>The <strong>Mean Corpuscular Volume (MCV)</strong> is a measure of the average volume of red blood cells (RBCs).</li>\n<li><strong>MCV &lt; 80 fL</strong>: Microcytic RBCs (e.g., iron deficiency anaemia, thalassemia</li>\n<li><strong>MCV 80-100 fL</strong>: Normocytic RBCs <strong>(Option B)</strong></li>\n<li><strong>MCV &gt; 100 fL</strong>: Macrocytic RBCs <strong>(Option A)</strong></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Hypochromic (Option D):</strong> Hypochromia refers to decreased haemoglobin concentration within the RBCs, causing them to appear pale. While microcytic anaemias (like iron deficiency anaemia) are often also hypochromic, MCV measures cell volume, not haemoglobin content. Hypochromia is assessed by MCH or MCHC.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillin injection</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Spherocytosis</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">G6PD deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male was admitted to the hospital due to jaundice. On investigation, it is found that the patient has haemolytic anaemia. Jaundice occurred due to excessive destruction of RBCs. Among the following, which is least likely to cause hemolytic anaemia?</span></p>",
      "unique_key": "DT1320747",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320747,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The question asks which condition is <strong>least likely</strong> to cause hemolytic anemia, which is characterized by the premature destruction of red blood cells leading to jaundice.</li>\n<li><strong>Iron deficiency anemia</strong> is a distinct type of anemia that results from insufficient iron for hemoglobin synthesis, leading to the production of small, pale red blood cells (microcytic, hypochromic anemia). It does not involve increased red blood cell destruction (hemolysis). Therefore, it is the least likely condition among the options to be associated with hemolytic anemia.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Penicillin injection (Option B):</strong> Penicillin can cause <strong>drug-induced immune hemolytic anemia</strong>. This occurs through a hapten-mediated mechanism, where antibodies lead to the destruction of red blood cells. This is a recognized cause of hemolytic anemia.</p>\n<p><strong>Spherocytosis (Option C):</strong> <strong>Hereditary spherocytosis</strong> is a classic cause of <strong>intrinsic hemolytic anemia</strong>. It involves defective red blood cell membrane proteins, causing the red blood cells to become spherical, get trapped in the spleen, and be prematurely destroyed. This is a common cause of hemolytic anemia.</p>\n<p><strong>G6PD deficiency (Option D):</strong> Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an <strong>intrinsic hemolytic anemia</strong> where red blood cells are susceptible to oxidative damage, leading to their premature destruction, especially when exposed to certain drugs or foods. This is a known cause of hemolytic anemia.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Hemolytic anemia</strong> is defined by the premature destruction of red blood cells.</li>\n<li><strong>Iron deficiency anemia</strong> results from impaired hemoglobin synthesis due to low iron and is not a hemolytic condition.</li>\n</ul>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild Anaemia</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Moderate Anaemia</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe Anaemia</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female visited the doctor due to fatigue and tiredness. The doctor took the history and immediately asked for the haemoglobin level in her plasma. It was 7.5 gm/dl. According to the haemoglobin level, it falls under which grade of anaemia?</span></p>",
      "unique_key": "DT1320748",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320748,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient's haemoglobin level of 7.5 gm/dL falls directly within the <strong>Severe anaemia</strong>. Anaemia grading based on haemoglobin levels is crucial for guiding clinical management and treatment decisions, ranging from dietary changes to urgent interventions like blood transfusions.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508214fda97f0-245b-4bf7-a4f5-aa1d993c80fb.png\">\n<p><strong>Reference: </strong>https://www.researchgate.net/figure/WHO-classification-of-anemia-according-to-age-and-severity_fig1_342207293</p>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyanosis does not occur in peripheral arterial disease</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">The patient has severe anaemia (Hb level 6 gm/dl)</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">The patient has polycythemia vera</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 49-year-old patient had severe peripheral arterial disease. On examination, the doctor tried to find an important sign, that is cyanosis, but he was not able to find it. What could be the probable reason for it?</span></p>",
      "unique_key": "DT1320750",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320750,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient's<strong> severe anaemia (Hb 6 gm/dl) </strong>is the probable reason cyanosis was not found. For cyanosis to be visible, at least <strong>5 g of deoxygenated haemoglobin per 100 ml of blood</strong> is required. With such low total haemoglobin, it is physiologically impossible to accumulate this threshold of deoxygenated haemoglobin.</p>\n<p><strong>Cyanosis:</strong></p>\n<ul>\n<li>Bluish discolouration due to <strong>increased deoxygenated haemoglobin</strong>.</li>\n<li><strong>Threshold for Detection:</strong> Requires <strong>&ge; 5 gm/dL of deoxygenated Hb</strong>.</li>\n<li><strong>Masking of Cyanosis:</strong>\n<ul>\n<li><strong>Severe Anaemia:</strong> With very low total Hb (e.g., &lt; 7-8 gm/dL), it's difficult to accumulate 5 gm/dL of deoxygenated Hb; thus, <strong>cyanosis may not be visible</strong>.</li>\n<li><strong>Carbon Monoxide (CO) Poisoning:</strong> Carboxyhemoglobin gives a cherry-red colour, masking cyanosis.</li>\n</ul>\n</li>\n<li><strong>Causes of Cyanosis:</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025082120146219-beed-41c2-9ffa-550d357c2dcf.png\"><br>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508212720d260-10dc-4e2f-9ede-6c11d00db099.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Cyanosis does not occur in peripheral arterial disease (Option A):</strong> Peripheral arterial disease (PAD) causes reduced blood flow, leading to pallor or ischemia, not typically cyanosis, which requires deoxygenated haemoglobin accumulation.</p>\n<p><strong>Patient has polycythemia vera (Option C):</strong> Polycythemia vera involves an abnormally high RBC count and haemoglobin level. This would make cyanosis more likely and prominent, as it's easier to accumulate the 5 gm/dL of deoxygenated haemoglobin required for detection.</p>\n<p><strong>None of the above (Option D):</strong> This is incorrect, as severe anaemia is a valid reason for masked cyanosis.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Cyanosis </strong>requires a minimum threshold of <strong>5 gm/dL deoxygenated haemoglobin </strong>for detection.</li>\n</ul>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemoglobin A</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemoglobin A2</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemoglobin F</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemoglobin S</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The haemoglobin is made up of heme and globin. If there are 2 alpha and 2 delta chains in globin, what type of haemoglobin is it?</span></p>",
      "unique_key": "DT1320752",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320752,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>HbA2 (&alpha;2&delta;2) </strong>is a minor adult haemoglobin (~2.5%), elevated in beta-thalassemia, aiding diagnosis.</p>\n<ul>\n<li><strong>Haemoglobin Structure:</strong> Tetramer composed of <strong>four globin chains</strong> (two alpha-like, two beta-like) and four heme groups.</li>\n<li><strong>Normal Adult Haemoglobin Types:</strong>\n<ul>\n<li><strong>Haemoglobin A (HbA):</strong> <strong>&alpha;2&beta;2</strong> (most prevalent, &gt;97%). <strong>(Option A)</strong></li>\n<li><strong>Haemoglobin A2 (HbA2):</strong> <strong>&alpha;2&delta;2</strong> (minor adult Hb, ~2.5%).</li>\n<li><strong>Haemoglobin F (HbF):</strong> <strong>&alpha;2&gamma;2</strong> (fetal haemoglobin, trace in adults, high oxygen affinity). <strong>(Option C)</strong></li>\n</ul>\n</li>\n<li><strong>Haemoglobin S (HbS):</strong> Associated with <strong>sickle cell anaemia</strong>. It's an abnormal Hb variant where <strong>glutamic acid is substituted by valine</strong> at position 6 on the <strong>beta (&beta;) globin chain</strong>. <strong>(Option D)</strong></li>\n</ul>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Methemoglobinemia</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell anaemia</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary spherocytosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old boy was evaluated by a paediatrician for weakness and easy fatigability. On investigation, the doctor identified that the patient had insufficient production of beta globin chains. What could be the probable diagnosis?</span></p>",
      "unique_key": "DT1320754",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320754,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The key finding of <strong>\"insufficient production of beta globin chains\"</strong> directly points to <strong>Thalassemia</strong>, specifically <strong>Beta-Thalassemia</strong>.</p>\n<p><strong>Thalassemia:</strong></p>\n<ul>\n<li><strong>Thalassemia</strong> is a group of <strong>inherited hemoglobinopathies</strong> caused by <strong>quantitative defects in globin chain synthesis</strong> (reduced or absent production).</li>\n<li>It results in <strong>unbalanced production</strong> of alpha or beta globin chains.</li>\n<li>This leads to <strong>ineffective erythropoiesis</strong> and <strong>increased hemolysis</strong>, causing <strong>anaemia</strong>.</li>\n<li><strong>Beta-thalassemia</strong> specifically involves <strong>reduced or absent synthesis of beta-globin chains</strong>.</li>\n<li>Common complications include <strong>splenomegaly</strong>, <strong>growth retardation</strong>, and <strong>iron overload</strong>.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025031846706c13-fc75-4224-a1bd-f25201f1b7c5.jpg\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Methemoglobinemia (Option A):</strong> Methemoglobinemia is a disorder where the iron in heme is oxidised to the ferric (Fe3+) state, preventing oxygen binding. It's a defect in oxygen transport due to iron oxidation, not a defect in globin chain production.</p>\n<p><strong>Sickle cell anaemia (Option B):</strong> Sickle cell anaemia involves a qualitative defect (a specific amino acid substitution) in the beta globin chain, leading to abnormal HbS structure, not insufficient production of the chain itself.</p>\n<p><strong>Hereditary spherocytosis (Option D):</strong> This is incorrect. Hereditary spherocytosis is caused by defects in red blood cell membrane proteins, which lead to abnormally shaped (spherical) and fragile RBCs that are prematurely destroyed. It does not involve a defect in globin chain synthesis.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>\"Insufficient production\" </strong>of globin chains strongly indicates <strong>Thalassemia.</strong></li>\n<li>Thalassemia is a <strong>quantitative hemoglobinopathy</strong>.</li>\n<li>Sickle cell disease is a <strong>qualitative hemoglobinopathy</strong>.</li>\n</ul>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein C</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Orosomucoid</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Macroglobulin</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceruloplasmin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male with Wilson's disease has low levels of a copper-carrying plasma protein. Which protein is this?</span></p>",
      "unique_key": "DT1320756",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320756,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Ceruloplasmin deficiency </strong>in<strong> Wilson's disease </strong>causes copper accumulation in tissues, leading to neurological and hepatic symptoms.</p>\n<p><strong>Ceruloplasmin:</strong></p>\n<ul>\n<li><strong>Synthesis</strong>: Ceruloplasmin is synthesised by the <strong>liver</strong>.</li>\n<li><strong>Primary function:</strong> It is the main <strong>copper transport protein</strong> in plasma.</li>\n<li><strong>Ferroxidase activity:</strong> Converts <strong>ferrous iron (Fe<sup>2+</sup>) to ferric iron (Fe<sup>3+</sup>),</strong> facilitating iron binding to <strong>transferrin.</strong></li>\n<li><strong>Role in iron metabolism:</strong> Supports iron <strong>mobilisation</strong> and <strong>utilisation</strong> by aiding in its oxidation.</li>\n<li><strong>Clinical relevance:</strong>\n<ul>\n<li><strong>Deficiency</strong> leads to <strong>Wilson's disease,</strong> characterised by <strong>copper accumulation</strong> in tissues.</li>\n<li>Also causes <strong>impaired iron metabolism</strong> due to reduced ferroxidase activity.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Protein C (Option A):</strong> Protein C is an important anticoagulant protein that helps regulate blood clotting by inactivating specific clotting factors. It does not carry copper.</p>\n<p><strong>Orosomucoid (Option B):</strong> Orosomucoid, also known as alpha-1 acid glycoprotein, is an acute-phase reactant involved in the inflammatory response. It is not a copper carrier.</p>\n<p><strong>Macroglobulin (Option C):</strong> Alpha-2 macroglobulin is a large plasma protein that primarily functions as a protease inhibitor and a carrier for various molecules, but it is not the primary carrier for copper.</p>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Malabsorption syndrome</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver disease</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrosis</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old female presents with oedema due to low plasma protein levels. What are the probable causes of her hypoproteinemia?</span></p>",
      "unique_key": "DT1320759",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320759,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Hypoproteinemia:</strong></p>\n<ul>\n<li>Decreased plasma protein levels.</li>\n<li><strong>Plasma Protein Synthesis:</strong> Primarily <strong>liver</strong> (most proteins like albumin, clotting factors), some by <strong>lymphocytes</strong> (gamma globulins/antibodies).</li>\n<li><strong>Causes of Hypoproteinemia:</strong>\n<ul>\n<li><strong>Decreased Synthesis:</strong>\n<ul>\n<li><strong>Liver Disease:</strong> Impaired hepatocellular function reduces protein production.<strong> (Option B)</strong></li>\n<li><strong>Severe Malnutrition/Starvation:</strong> Insufficient protein intake for synthesis.</li>\n</ul>\n</li>\n<li><strong>Increased Loss:</strong>\n<ul>\n<li><strong>Nephrotic Syndrome (Nephrosis):</strong> Glomerular damage leads to significant <strong>proteinuria</strong> (protein loss in urine).<strong> (Option C)</strong></li>\n<li><strong>Malabsorption Syndrome:</strong> Reduced absorption of dietary proteins from the gut. <strong>(Option A)</strong></li>\n<li><strong>Severe Burns:</strong> Large protein loss through exudate from damaged skin.</li>\n<li><strong>Protein-Losing Enteropathy:</strong> Excessive protein loss via the gastrointestinal tract.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Effects:</strong></p>\n<ul>\n<li>Decreased <strong>albumin</strong> &rarr; decreased <strong>osmotic pressure</strong> &rarr; <strong>oedema</strong></li>\n<li>Decreased <strong>globulin</strong> &rarr; decreased <strong>immunity</strong></li>\n<li>Decreased <strong>fibrinogen and clotting factors</strong> &rarr; <strong>bleeding tendency</strong></li>\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Microcytic hypochromic anaemia</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Aplastic anemia</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemolytic anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 51-year-old male has oropharyngeal cancer. He has been on chemotherapy treatment for 2 months. Due to exposure to chemotherapy, which type of anaemia may occur in this patient?</span></p>",
      "unique_key": "DT1320764",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320764,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Aplastic anemia</strong> is a condition characterised by bone marrow failure, resulting in a significant reduction in the production of red blood cells, white blood cells, and platelets. Therefore, <strong>prolonged chemotherapy</strong> is a common cause of aplastic anemia.</p>\n<ul>\n<li><strong>Aplastic Anaemia:</strong> Characterised by <strong>pancytopenia</strong> (reduction in all three blood cell lines: RBCs, WBCs, platelets) due to <strong>bone marrow failure</strong>.</li>\n<li><strong>Causes of Aplastic Anaemia:</strong>\n<ul>\n<li><strong>Acquired:</strong>\n<ul>\n<li><strong>Chemotherapy/Radiation:</strong> Most common iatrogenic cause due to direct myelosuppression.</li>\n<li>Drugs (e.g., chloramphenicol, NSAIDs, sulfonamides).</li>\n<li>Viruses (e.g., parvovirus B19, hepatitis viruses, HIV).</li>\n<li>Autoimmune disorders.</li>\n<li>Toxins (e.g., benzene).</li>\n</ul>\n</li>\n<li><strong>Inherited:</strong> Fanconi anaemia.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Microcytic hypochromic anaemia (Option A):</strong> While chemotherapy can indirectly affect iron status, microcytic hypochromic anaemia is primarily linked to iron deficiency or globin chain synthesis defects (e.g., thalassemia), not directly to chemotherapy-induced bone marrow suppression.</p>\n<p><strong>Megaloblastic anaemia (Option C):</strong> Megaloblastic anaemia results from B12 or folate deficiency. While some chemotherapies (e.g., methotrexate) inhibit folate metabolism, aplastic anemia is the primary consequence of most myelosuppressive agents.</p>\n<p><strong>Hemolytic anaemia (Option D):</strong> Hemolytic anaemia involves the destruction of red blood cells, not primarily a reduction in their production due to bone marrow suppression. While some chemotherapies can rarely cause hemolysis, it's not the characteristic or primary type of anaemia associated with general chemotherapy-induced bone marrow toxicity.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Chemotherapy's</strong> main impact on blood cells is myelosuppression, leading to <strong>aplastic anemia.</strong><br /> </li>\n</ul>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in the viscosity of blood</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperdynamic circulation</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased pumping load on the heart</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in peripheral blood flow</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female with anaemia presents with fatigue and tachycardia. Which effect is not associated with her condition?</span></p>",
      "unique_key": "DT1320765",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320765,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Anaemia</strong> leads to a <strong>reduced red blood cell (RBC) count,</strong> which is the primary determinant of blood viscosity.</li>\n<li>Therefore, <strong>blood viscosity decreases</strong> in anemia, not increases.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Hyperdynamic circulation (Option B)</strong>: Due to decreased viscosity and compensatory mechanisms, cardiac output increases and blood flow speeds up, creating a hyperdynamic state.</p>\n<p><strong>Increased pumping load on the heart (Option C)</strong>: The heart must pump more blood to compensate for reduced oxygen delivery, increasing its workload.</p>\n<p><strong>Increase in peripheral blood flow (Option D)</strong>: Generalised vasodilation occurs along with higher cardiac output, resulting in increased peripheral perfusion to tissues.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Anaemia</strong> is associated with <strong>decreased blood viscosity, hyperdynamic circulation, elevated cardiac workload,</strong> and <strong>increased peripheral blood flow.</strong></li>\n<li><strong>Increased viscosity</strong> is not seen in anaemia; it is characteristic of <strong>polycythemia.</strong></li>\n</ul>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Vit B12 deficiency</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid deficiency</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Intrinsic factor deficiency</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old male with megaloblastic anaemia is diagnosed with pernicious anaemia. What is the primary cause of his condition?</span></p>",
      "unique_key": "DT1320767",
      "question_audio": null,
      "question_video": null,
      "map_id": 1320767,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Pernicious anaemia</strong> is specifically defined as a type of megaloblastic anaemia caused by a deficiency of <strong>Intrinsic Factor (IF)</strong>.</p>\n<ul>\n<li><strong>Pernicious Anaemia (PA):</strong>\n<ul>\n<li>Specific type of <strong>megaloblastic anemia</strong>.</li>\n<li><strong>Primary Cause:</strong> <strong>Intrinsic Factor (IF) deficiency</strong>.</li>\n<li><strong>Mechanism:</strong> Lack of IF leads to <strong>impaired Vitamin B12 absorption</strong>, causing functional B12 deficiency.</li>\n<li><strong>Common Aetiology:</strong> Autoimmune destruction of gastric parietal cells (leading to IF deficiency and achlorhydria) or gastric surgery.</li>\n</ul>\n</li>\n<li><strong>Intrinsic Factor (IF):</strong> Glycoprotein secreted by <strong>gastric parietal cells</strong>.\n<ul>\n<li>Binds to dietary Vitamin B12.</li>\n<li>Essential for Vitamin B12 absorption in the <strong>terminal ileum</strong>.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Vit B12 deficiency (Option A): </strong>Vitamin B12 deficiency is a consequence of intrinsic factor deficiency in pernicious anaemia, not the primary cause.</p>\n<p><strong>Folic acid deficiency (Option B):</strong> Folic acid deficiency also causes megaloblastic anaemia, but it is not the cause of pernicious anaemia. Pernicious anaemia is specifically linked to Vitamin B12 malabsorption due to Intrinsic Factor deficiency. <br /> </p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}